Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL2389210 | 0.95 | TSHR (0.47) | TSHREPHX2POLBAPEX1HTT | |
| SCHEMBL17491125 | 0.93 | TSHR (0.44) | TSHRACHECNR2TRPV1HCAR2 | |
| Acrylic Acid SCHEMBL578219 | 0.89 | TSHR (0.44) | TSHRACHEEPHX2CNR2TRPV1 | |
| Acrylic Acid SCHEMBL9388200 | 0.87 | TSHR (0.50) | TSHREPHX2POLBAPEX1HTT | |
| Acrylic Acid SCHEMBL5291299 | 0.85 | TSHR (0.44) | TSHRACHEHCAR2HPGDTHRB | |
| Acrylic Acid SCHEMBL9957502 | 0.84 | TSHR (0.41) | TSHRACHEHPGDTHRB | |
| Acrylic Acid SCHEMBL8415350 | 0.84 | TSHR (0.44) | TSHREPHX2HCAR2HPGD | |
| Acrylic Acid SCHEMBL18788237 | 0.84 | TSHR (0.45) | TSHRACHEPOLBAPEX1HTT | |
| Acrylic Acid SCHEMBL21239504 | 0.84 | ZDHHC20 (0.50) | TSHRACHEEPHX2 | |
| Acrylic Acid SCHEMBL5282179 | 0.83 | TSHR (0.48) | TSHRACHEPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8597619-B2 | Thickener or gellant for oil materials, gel composition comprising same, and method of producing cosmetic material or topical agent | Dow Corning Toray., Ltd. (JP) | 2013-12-03 | — | — | US | disclosed |
| US-20120328539-A1 | Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent | DOW TORAY CO., LTD. (JP) | 2012-12-27 | — | — | US | disclosed |
| EP-2516511-A2 | THICKENER OR GELLANT FOR OIL MATERIALS, GEL COMPOSITION COMPRISING SAME, AND METHOD OF PRODUCING COSMETIC MATERIAL OR TOPICAL AGENT | Dow Corning Toray Co., Ltd. (JP) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011078395-A2 | THICKENER OR GELLANT FOR OIL MATERIALS, GEL COMPOSITION COMPRISING SAME, AND METHOD OF PRODUCING COSMETIC MATERIAL OR TOPICAL AGENT | DOW CORNING TORAY CO., LTD. (JP) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120328539-A1 | Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent | H1-10, F12, RPS12 | TSHR 3010/4885ACHE 2281/4885EPHX2 2077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.